Cellectis Inc - Company & Market Research Reports

Cellectis is a gene-editing company that develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company designs novel products including immune therapies for cancer and enzymes which can add DNA at targeted places in genomes. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. Cellectis S.A. was founded in 1999 and is based in Paris, France.


Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) - Reagents & Tools, Services, Cell Lines, Models - Product Thumbnail Image

Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other) - Reagents & Tools, Services, Cell Lines, Models

  • Report
  • 167 Pages
From
France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

France Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 158 Pages
From
Cell Therapy Manufacturing Market, 2017-2027 - Product Thumbnail Image

Cell Therapy Manufacturing Market, 2017-2027

  • Report
  • 280 Pages
From
Gene Therapy Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Gene Therapy Market (2nd Edition), 2018-2030

  • Report
  • 555 Pages
From
Global Gene Therapy Market Analysis & Forecast to 2022 - Product Thumbnail Image

Global Gene Therapy Market Analysis & Forecast to 2022

  • Report
  • 310 Pages
From
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014 - 2025

  • Report
  • 150 Pages
From
BCMA Targeted Therapies, 2017-2030 - Product Thumbnail Image

BCMA Targeted Therapies, 2017-2030

  • Report
  • 143 Pages
From
Global CAR T Cell Therapy Market & Clinical Trials Insight 2022 - Product Thumbnail Image

Global CAR T Cell Therapy Market & Clinical Trials Insight 2022

  • Drug Pipelines
  • 240 Pages
From
Genome Editing Global Market-Forecast to 2022 - Product Thumbnail Image

Genome Editing Global Market-Forecast to 2022

  • Report
  • 273 Pages
From
The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More - Product Thumbnail Image

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More

  • Report
  • 123 Pages
From
Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023 - Product Thumbnail Image

Global CRISPR Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • Report
  • 140 Pages
From
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025

  • Report
  • 185 Pages
From
Genome Editing: Technologies and Global Markets - Product Thumbnail Image

Genome Editing: Technologies and Global Markets

  • Report
  • 129 Pages
From
The Market and Potential for CRISPR/Cas9 Gene Editing - Product Thumbnail Image

The Market and Potential for CRISPR/Cas9 Gene Editing

  • Report
  • 101 Pages
From
CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report - Product Thumbnail Image

CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report

  • Report
  • 70 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Strategic Development of Neural Stem & Progenitor Cell Products (2018) - Product Thumbnail Image

Strategic Development of Neural Stem & Progenitor Cell Products (2018)

  • Report
  • 210 Pages
From
Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report - Product Thumbnail Image

Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report

  • Report
  • 107 Pages
From
iPS cell Generation patent landscape - 2013/03 - Product Thumbnail Image

iPS cell Generation patent landscape - 2013/03

  • Report
Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview - Product Thumbnail Image

Tissue Engineering: The Combination of Cells & Engineering - A Global Market Overview

  • Report
  • 153 Pages
From
Loading Indicator
adroll